Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene stock (NYSE: CNC) currently trades at $73 per share, roughly 25% below its pre-inflation peak level of $97 seen in August 2022, faring much worse than its peer – Molina Healthcare stock (NYSE: MOH) – which has largely traded sideways over this period. The recent fall in CNC stock can be attributed to its updated estimate of 13 million Medicaid members by the end of this year, versus its prior estimate of 13.6 million members.

What's Happening With Centene Stock?

CNC's unit, Iowa Total Care, wins a new contract to provide Medicaid managed care services, enhancing its presence in Iowa and bringing improved health outcomes in the state.

Centene's Unit Secures New Four-Year Medicaid Contract in Iowa

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Here's Why Centene (CNC) is a Strong Value Stock

Funding will Support Youth Impacted by Domestic Violence Across the State RALEIGH, N.C. , Sept. 4, 2024 /PRNewswire/ -- WellCare of North Carolina  (WellCare), a Medicaid health plan and a Centene Corporation (NYSE: CNC) company, announced today a $100,000 donation available to nine Family Justice Centers across North Carolina.

WellCare of North Carolina Donates $100,000 to Support Camp HOPE America

Shares of health insurers lost ground Wednesday as executives at Centene (CNC) warned about a pullback in the number of people receiving Medicaid benefits.

Health Insurer Stocks Tumble on Medicaid Enrollment Concerns

Shares of major players in the Medicaid business dropped sharply Wednesday after Centene Corp. executives spoke about ongoing tumult in the joint federal and state program.

Centene's Medicaid pressures weigh on stocks of major insurers

ST. LOUIS , Sept. 4, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today that its Iowa-based subsidiary, Iowa Total Care, has been selected by the Iowa Department of Health and Human Services (HHS) to continue providing Medicaid managed care services under the Iowa Health Link program.

CENTENE SUBSIDIARY IOWA TOTAL CARE AWARDED STATEWIDE MEDICAID CONTRACT

CNC gains from improved premiums and service revenues, acquisitions and adequate operating cash flows.

Centene Stock Rises 29% in a Year: Evaluating the Road Ahead

The relocation of the facility is expected to enhance CNC's specialty pharmacy capabilities and patient care services.

Centene Shifts an AcariaHealth Facility to Shelby Township

ST. LOUIS , Aug. 29, 2024  /PRNewswire/ -- Centene Corporation (NYSE: CNC), a leading healthcare enterprise committed to helping people live healthier lives, announced today it will present at the 2024 Wells Fargo Healthcare Conference. Centene will present on Wednesday, September 4 at 8:45 a.m.

CENTENE TO PRESENT AT 2024 WELLS FARGO HEALTHCARE CONFERENCE

With Second Pharmacy Relocation This Year, AcariaHealth Emphasizes Commitment to Enhancing Patient Care, Empowering Employees, and Engaging Community DETROIT , Aug. 28, 2024 /PRNewswire/ -- AcariaHealth, a national specialty pharmacy focused on improving care and outcomes for patients living with complex medical conditions and a Centene company (NYSE: CNC), announced the relocation of its Homescripts pharmacy, a national leader in free goods service supporting patient medication access and adherence, to Shelby Township, Michigan. This new, nearly 33,000 square foot Detroit-area facility will provide ample space for business and pharmacy operations.

AcariaHealth Invests in Free Goods Program, Opening Modern Specialty Pharmacy Facility in Shelby Township, Michigan

Centene Corporation is a financially healthy company but is assessed a Hold opportunity for retail value investors due to political uncertainties about government healthcare programs and lack of a dividend. Despite a positive Q2 '24 earnings report, Centene stock has exhibited high volatility and faces growth challenges. Risks for investors include reliance on government programs, potential regulatory changes, and limited growth opportunities in the healthcare sector.

Manage Centene Corp. Conservatively Like They Manage Their Money

Centene has a 10-year price return of 313.77%, almost double the 179.34% price return of the S&P 500. The company is strategically positioned in the market, and the current favorable trends serve as major growth levers. The stock is undervalued, making it a decent buy.

Centene Corporation: Strategic Market Position Amid Favorable Trends, Buy

Why Centene (CNC) is a Top Value Stock for the Long-Term

ST. LOUIS , Aug. 15, 2024 /PRNewswire/ -- Centene Corporation (NYSE: CNC) ("the Company") announced today that it has appointed Thomas R. Greco to the Centene Board of Directors, effective Aug. 9, 2024.

CENTENE ANNOUNCES THE ELECTION OF THOMAS GRECO TO BOARD OF DIRECTORS

The funding is made available through a quarterly program open to community-based organizations and providers across Texas AUSTIN, Texas , Aug. 13, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), has announced the latest recipients of its quarterly community and provider grant program. The funding is targeted to address the needs of low-income neighborhoods and communities in Texas.

Superior HealthPlan Awards $24,000 in Grants to 12 Nonprofits and Providers

Partnerships with local clinics, providers, community-based organizations and others provide students with backpacks, resources and information . SACRAMENTO, Calif.

8,000 California Youth to Receive Backpacks from Health Net to Support their Education Ahead of the 2024-25 School Year

Eligible Community Organizations and Schools Encouraged to Apply. AUSTIN, Texas , Aug. 1, 2024 /PRNewswire/ -- Superior HealthPlan ("Superior"), a leading managed care organization in Texas and a company of Centene Corporation (NYSE: CNC), is commemorating 25 years of serving Texans by encouraging eligible community organizations and schools to apply for the Superior HealthPlan Anniversary Grant Program.

Superior HealthPlan 25th Anniversary Grant Program Now Open

Pilot Program Now Fully Launched and Available to Members in all 100 N.C. Counties RALEIGH, N.C.

WellCare of North Carolina and Expressable Expand Advanced Speech Therapy Program Across the State

Funds to support 25 tiny homes and the implementation of a new crisis response program SACRAMENTO, Calif. , July 30, 2024 /PRNewswire/ -- Today, Health Net, one of California's most experienced Medi-Cal managed care health plans and a Centene Corporation (NYSE: CNC) company, announced a $1.3 million grant to the City of Redondo Beach.

Unhoused to Receive Temporary Housing and Health Care Services in Redondo Beach Thanks to $1.3 Million Grant from Health Net

TAMPA, Fla., July 31, 2024 /PRNewswire/ -- Big Brothers Big Sisters of America (BBBSA), the nation's preeminent one-to-one youth mentoring organization, today announced the election of its newest Board member, Centene Corporation [Centene] (NYSE: CNC) Executive Vice President (EVP) of External Affairs, Jonathan Dinesman.

Big Brothers Big Sisters of America Appoints Centene Corporation's Jonathan Dinesman to National Board

Health Net Assisting Members During State of Emergency SACRAMENTO, Calif. , July 29, 2024 /PRNewswire/ -- In response to Gov.

Health Net Providing Special Assistance to Members Affected by the Gold Complex and Park Fires Throughout California

Centene (CNC) shares jumped in intraday trading Friday as the managed care provider reported better-than-expected profit and sales and raised its guidance as its premium and services sales and members increased.

Centene Beats Estimates, Boosts Guidance on Higher Premiums, Memberships

Centene's (CNC) second-quarter earnings suffer from rising operating expenses and a decline in Medicaid membership levels. Improved Marketplace membership growth partially offset the negatives.

Centene (CNC) Q2 Earnings Miss on Declining Medicaid Membership

Centene Corporation. (NYSE:CNC ) Q2 2024 Earnings Conference Call July 26, 2024 8:30 AM ET Company Participants Jennifer Gilligan - SVP, Finance and Investor Relations Sarah London - Chief Executive Officer Andrew Asher - EVP and Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Justin Lake - Wolfe Research Josh Raskin - Nefron Research A.J.

News for Centene Stock (CNC)